This is a Validated Antibody Database (VAD) review about human OX40, based on 16 published articles (read how Labome selects the articles), using OX40 antibody in all methods. It is aimed to help Labome visitors find the most suited OX40 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
OX40 synonym: ACT35; CD134; IMD16; OX40; TXGP1L

BioLegend
mouse monoclonal (Ber-ACT35 (ACT35))
  • mass cytometry; human; loading ...; fig s4a
BioLegend OX40 antibody (Biolegend, 350015) was used in mass cytometry on human samples (fig s4a). Biomark Res (2022) ncbi
mouse monoclonal (Ber-ACT35 (ACT35))
  • flow cytometry; human; loading ...; fig 2b
BioLegend OX40 antibody (Biolegend, 350012) was used in flow cytometry on human samples (fig 2b). Cell (2020) ncbi
mouse monoclonal (Ber-ACT35 (ACT35))
  • flow cytometry; human; loading ...; fig 2
BioLegend OX40 antibody (Biolegend, BER-ACT35) was used in flow cytometry on human samples (fig 2). Biol Blood Marrow Transplant (2018) ncbi
mouse monoclonal (Ber-ACT35 (ACT35))
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend OX40 antibody (BioLegend, Ber-ACT35) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (Ber-ACT35 (ACT35))
  • mass cytometry; human; fig s8
BioLegend OX40 antibody (BioLegend, 350002) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
mouse monoclonal (Ber-ACT35 (ACT35))
  • flow cytometry; human; fig 4c
BioLegend OX40 antibody (Biolegend, Ber-ACT35) was used in flow cytometry on human samples (fig 4c). PLoS Pathog (2017) ncbi
mouse monoclonal (Ber-ACT35 (ACT35))
  • flow cytometry; human; loading ...; fig s6b
In order to assess whether human T-cell leukemia virus type 1 bZIP factor enhances the proliferation of expressing T cells after stimulation via the T-cell receptor, BioLegend OX40 antibody (BioLegend, Ber-ACT35) was used in flow cytometry on human samples (fig s6b). PLoS Pathog (2017) ncbi
Invitrogen
mouse monoclonal (ACT35 (ACT-35))
  • flow cytometry; human; loading ...; fig s5b
Invitrogen OX40 antibody (Invitrogen, 11-1347-42) was used in flow cytometry on human samples (fig s5b). Mol Cancer (2022) ncbi
mouse monoclonal (ACT35 (ACT-35))
  • flow cytometry; human; loading ...
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, Invitrogen OX40 antibody (eBioscience, ACT35) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (E9U7O)
  • immunohistochemistry; mouse; loading ...; fig 2y
Cell Signaling Technology OX40 antibody (Cell Signaling, E9U70) was used in immunohistochemistry on mouse samples (fig 2y). J Immunol (2019) ncbi
BD Biosciences
mouse monoclonal (ACT35)
  • flow cytometry; human
BD Biosciences OX40 antibody (BD Biosciences, 563663) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (ACT35)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences OX40 antibody (BD Biosciences, ACT35) was used in flow cytometry on human samples (fig 7a). Sci Rep (2017) ncbi
mouse monoclonal (ACT35)
  • flow cytometry; human; loading ...; fig 3a
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BD Biosciences OX40 antibody (BD Biosciences, ACT35) was used in flow cytometry on human samples (fig 3a). Clin Exp Immunol (2017) ncbi
mouse monoclonal (ACT35)
  • flow cytometry; human; loading ...; fig 6a
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences OX40 antibody (BD Biosciences, ACT35) was used in flow cytometry on human samples (fig 6a). Oncotarget (2016) ncbi
mouse monoclonal (ACT35)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences OX40 antibody (BD, 555838) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (ACT35)
  • flow cytometry; human
BD Biosciences OX40 antibody (BD Pharmingen, 555838) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Articles Reviewed
  1. Jung K, Son M, Lee S, Kim J, Ko D, Yoo S, et al. Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy. Mol Cancer. 2022;21:102 pubmed publisher
  2. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  3. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  4. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  5. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed publisher
  6. Hutten T, Norde W, Woestenenk R, Wang R, Maas F, Kester M, et al. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:666-677 pubmed publisher
  7. Liaskou E, Jeffery L, Chanouzas D, Soskic B, Seldin M, Harper L, et al. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals. Sci Rep. 2017;7:7652 pubmed publisher
  8. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  9. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  10. Yoder A, Guo K, Dillon S, Phang T, Lee E, Harper M, et al. The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria. PLoS Pathog. 2017;13:e1006226 pubmed publisher
  11. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  12. Kinosada H, Yasunaga J, Shimura K, Miyazato P, Onishi C, Iyoda T, et al. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors. PLoS Pathog. 2017;13:e1006120 pubmed publisher
  13. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  14. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  15. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  16. Reichwald K, Jørgensen T, Skov S. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS ONE. 2014;9:e105627 pubmed publisher